WALDENSTRÖM MACROGLOBULINEMIA (WM)
Clinical trials for WALDENSTRÖM MACROGLOBULINEMIA (WM) explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM MACROGLOBULINEMIA (WM) trials appear
Sign up with your email to follow new studies for WALDENSTRÖM MACROGLOBULINEMIA (WM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in controlling rare blood cancer
Disease control OngoingThis study tested a daily oral medication called acalabrutinib for people with Waldenström macroglobulinemia, a rare type of blood cancer. It involved 107 adults, including those whose cancer returned after prior treatment and some newly diagnosed patients. The main goal was to s…
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA (WM)
Phase: PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Study asks: does 'Watching' cancer cause more worry than treatment?
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how the 'watch and wait' approach affects the quality of life for Korean patients with slow-growing lymphomas. Researchers will survey 250 patients who are currently monitoring their cancer without active treatment to measure their anxiety, distress,…
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA (WM)
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:23 UTC